0001127602-12-014940.txt : 20120430
0001127602-12-014940.hdr.sgml : 20120430
20120430165833
ACCESSION NUMBER: 0001127602-12-014940
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120427
FILED AS OF DATE: 20120430
DATE AS OF CHANGE: 20120430
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morris Charles Q
CENTRAL INDEX KEY: 0001489966
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29815
FILM NUMBER: 12795920
MAIL ADDRESS:
STREET 1: C/O ALLOS THERAPEUTICS, INC.
STREET 2: 11080 CIRCLEPOINT ROAD, SUITE 200
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALLOS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001097264
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 541655029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11080 CIRCLEPOINT ROAD
STREET 2: SUITE 200
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
BUSINESS PHONE: 3034266262
MAIL ADDRESS:
STREET 1: 11080 CIRCLEPOINT ROAD
STREET 2: SUITE 200
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
4
1
form4.xml
PRIMARY DOCUMENT
X0305
4
2012-04-27
0001097264
ALLOS THERAPEUTICS INC
ALTH
0001489966
Morris Charles Q
11080 CIRCLEPOINT ROAD
SUITE 200
WESTMINSTER
CO
80020
1
Chief Medical Officer
Common Stock
2012-04-27
4
S
0
7970
1.8101
D
665323
D
These shares are being sold pursuant to a 10b5-1 plan for Charles Q. Morris in order to cover the withholding tax and other costs associated with such sale (i.e., wire fees, commission or interest) in connection with the vesting of restricted stock units on April 26, 2012.
/s/ David C. Clark, Attorney-in-Fact for Charles Q. Morris
2012-04-30